Differences in Debris Captured According to Valve Type

During valve replacement, cerebral protection systems may capture debris in up to 99% of all patients. In over half of them, these particles are >1 mm.

protecion cerebral en tavrThe particles captured during procedures in which Evolut R or Lotus valves were used were more and larger compared with those captured with the Sapien balloon-expandable valve. Beyond differences among valves, knowing that almost all patients present some kind of debris supports the eventual universal use of cerebral protection devices during TAVR.

 

Other recent studies had not discussed the lack of risk factors that might predict which patients would benefit more from protection systems and, without being able to select them correctly, all we could do was use these devices in all procedures. The cost/benefit relation of this is a different issue that should be assessed separately.


Read also: MitraClip in Severe MR: 5 Year Mortality Rate Similar to Surgery.


In this study, recently published in J Am Coll Cardiol Intv, a cerebral protection system (Claret Medical Sentinel, Santa Rosa, California) was used in an attempt to determine whether there were differences in size and number of debris based on the different valves used. A total of 246 patients from 2 prospective studies, SENTINEL (n = 100) and SENTINEL-H (n = 146), were included. The analysis of debris captured differentiated it by particle size (≥150, ≥500, and ≥1000 μm), particle count, total particle area, and maximum of largest dimension. The valves used were Evolut R (16%), Lotus (15%), Sapien 3 (59%), and Sapien XT (10%).

 

There was a higher amount of debris related to the vascular bed (valve tissue, arterial wall, calcification) in patients who received an Evolut R valve compared with patients who received a Sapien 3 valve. Beyond that, all valves resulted in at least one particle >1 mm. Large particles (≥500 and ≥1000 μm) were significantly more frequent with Evolut R and Sapien 3 valves. Particles ≥1000 µm were more frequent with Lotus valves.


Read also: Endovascular Therapy in Stroke: Much Evidence and Few Trained Operators.


Self-expanding valves presented higher particle count, total particle area, and maximum of largest dimension than both balloon-expandable models.

 

Conclusion

Debris was captured in 99% of patients, over half of whom had particles >1 mm. Regardless of differences in debris number and size among valves, their universal finding may support the use of cerebral protection devices in all patients undergoing TAVR.

 

Original title: Debris Heterogeneity Across Different Valve Types Captured by a Cerebral Protection System During Transcatheter Aortic Valve Replacement.

Reference: Tobias Schmidt et al. J Am Coll Cardiol Intv 2018;11:1262-73.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Coronary Obstruction During TAVI: A New Volumetric Index to Consider

Coronary obstruction during TAVI is an uncommon but potentially catastrophic complication, particularly in valve-in-valve procedures, in anatomies with small sinuses of Valsalva, low coronary...

EARLY TAVR: Impact of Age on Outcomes of Early TAVR in Asymptomatic Patients

Asymptomatic severe aortic stenosis represents an increasingly common clinical challenge. Although current guidelines recommend intervention once symptoms develop or left ventricular dysfunction occurs, concerns...

T-TEER: Beyond Traditional Pulmonary Hypertension Thresholds

Significant tricuspid regurgitation (TR) is associated with progressive functional deterioration, heart failure (HF) hospitalizations, and increased mortality. In recent years, transcatheter tricuspid edge-to-edge repair...

Is left atrial appendage closure safe in patients with reduced ejection fraction?

Patients with heart failure with reduced ejection fraction (HFrEF) were excluded from the major randomized trials evaluating percutaneous left atrial appendage closure (LAAC), and...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

SPYRAL Program: 3-Year Outcomes in Patients Treated with Renal Denervation

Hypertension is the leading modifiable risk factor for cardiovascular disease and remains a major global health challenge, affecting more than one billion adults worldwide.  Despite...

Coronary Obstruction During TAVI: A New Volumetric Index to Consider

Coronary obstruction during TAVI is an uncommon but potentially catastrophic complication, particularly in valve-in-valve procedures, in anatomies with small sinuses of Valsalva, low coronary...

EARLY TAVR: Impact of Age on Outcomes of Early TAVR in Asymptomatic Patients

Asymptomatic severe aortic stenosis represents an increasingly common clinical challenge. Although current guidelines recommend intervention once symptoms develop or left ventricular dysfunction occurs, concerns...